3 ms·

Woah that's a contrarian take on obesity. Can you elaborate?

• anovikov 4y ago
  GLP-1 receptor agonists seem to be the one-and-for-all solution for obesity and they seem to work for nearly every person regardless of existing health conditions, diabetes, etc (they are primarily diabetes drugs) with under 3% quit rate from side effects. Only problem is production volumes ramp-up but that will solve itself over time just like with covid vaccines, because drugs are new, 2021-2022. Smart asses willing to pay ~$1500+ per month already all got access to them. In 3-4 years, at least in developed countries, only people who will still be fat are those with rare and unusual health issues, rare people with extreme side effects to these drugs, and those who don't care. In another few years, health insurance will probably be unaccessible to those who are overweight and don't use these drugs so it will not even be a choice.